The Worldwide Nutrigenomics Industry is Expected to Reach $2.6 Billion by 2031 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Oct 6, 2022--

The "Global Nutrigenomics Market 2021-2031 by Offering, Test Technology, Test Sample, Application, End User, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

The global nutrigenomics market will reach $2,691.3 million by 2031, growing by 15.2% annually over 2021-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.

This report is based on a comprehensive research of the entire global nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Region.

Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Products
• Probiotics
• Prebiotics
• Vitamins & Supplements
• Testing Services
• Nutrigenomics Clinical Testing
• Nutrigenomics Research Testing

Based on Test Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Next-generation Sequencing
• Real-time PCR
• DNA Microarray
• Sanger Sequencing

By Test Sample, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Buccal Swab Sample
• Saliva Sample
• Blood Sample
• Other Samples

By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Women's Health
• Metabolic Disorders
• Immune Health
• Cancer Research
• Cardiovascular Diseases
• Diabetes
• Other Applications

By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospitals
• Nutrition Clinics
• Diagnostics Laboratories
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market by Offering,Application and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players

• BASF SE
• BioGaia
• Cell Logic
• Cura Integrative Medicine
• DNAfit
• DuPont de Nemours, Inc.
• Garden of Life, LLC
• GeneOmbio
• Genova Diagnostics, Inc.
• GX Sciences, Inc.
• Ingredion Incorporated
• Jarrow Formulas Inc.
• Koninklijke DSM N.V.
• MedGenome
• Metagenics, Inc.
• Nutrigenomix Inc.
• Unilever Group
• XCODE Life
• Yakult Honsha Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/k6do2a

View source version on businesswire.com:https://www.businesswire.com/news/home/20221006005556/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: FITNESS & NUTRITION HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2022.